Millennium Pharmaceuticals, Inc. (MLNM) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	1/8/2007 1:43:32 AM
	Read Replies (1) of 3044

Millennium Pharmaceuticals "underperform," target price reduced Saturday, January 06, 2007 12:20:34 PM ET Friedman,Billings,Ramsey &Co NEW YORK, January 6 (newratings.com) - In a research note published yesterday, analysts at Friedman Billings reiterate their "underperform" rating on Millennium Pharmaceuticals (MLNM.NAS). The target price has been reduced from $8 to $7.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next